Right heart thrombi in pulmonary embolism

Adam Torbicki, Nazzareno Galiè, Anna Covezzoli, +3

Journal of the American College of Cardiology

ThrombosisPulmonary EmbolismVenous ThrombosisCardiovascular DiseaseHematology +4

Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss

Penelope Brock, Rudolf Maibach, Margaret Childs, +21

New England Journal of Medicine

Gender comparisons in pulmonary embolism (results from the International Cooperative Pulmonary Embolism Registry [ICOPER])

Kathleen Mchugh, Luigi Visani, Marisa DeRosa, +3

The American Journal of Cardiology

ThrombosisPulmonary EmbolismVenous ThrombosisCardiovascular DiseasePatient Safety +6

Three years of experience: the Italian registry and safety data update

Gianluigi Mancardi, G. Tedeschi, Maria Pia Amato, +21

Neurological Sciences

EpidemiologyEngineeringSafety ManagementHealth PolicyRisk Management +9

Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions

Carlotta Biagi, Valentino Conti, Nicola Montanaro, +9

European Journal of Clinical Pharmacology

Drug SafetyAdverse Drug ReactionsMedicineAdverse Drug ReactionPatient Safety +7

Use of aliskiren in a ‘real-life’ model of hypertension management

Massimo Volpe, Giuliano Tocci, Francesca Bianchini, +4

Journal of Hypertension

The pharmacovigilance program on natalizumab in Italy: 2 years of experience

G. Tedeschi, Maria Pia Amato, Roberto D’Alessandro, +21

Neurological Sciences

Drug SafetyMedicineDrug DiscoveryPharmacovigilancePharmacotherapy +5

Disease Management of the Metabolic Syndrome in a Community: Study Design and Process Analysis on Baseline Data

Nazario Melchionda, Gabriele Forlani, Lucia La Rovere, +7

Metabolic Syndrome and Related Disorders

Natalizumab: a country-based surveillance program

Gianluigi Mancardi, Maria Pia Amato, Roberto D’Alessandro, +15

Neurological Sciences

International HealthDisease OutbreakDisease SurveillancePublic HealthEpidemic Intelligence +3